Dr. Borriello was a featured speaker at a live webinar entitled “Adapting to Immuno-Oncology’s R&D Challenges: Refocusing on Innate Immunity as the ‘Next Big Thing’ in Cancer Immunotherapy”.
The live webinar, moderated by Lumanity, brought together a diverse array of biotech companies with a range of platforms and modalities to modulate innate pathways, with the goal of enhancing the ability of the patient’s immune system to control cancer (with or without immune checkpoint inhibitors).
Date recorded: Wednesday, October 23, 2024
To request interviews, high res images or other materials, media are asked to:
Email: media@alloplexbio.com
Attn: Lesley White, Alloplex Australia
For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013
